Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRN on omega-3s

This article was originally published in The Tan Sheet

Executive Summary

A white paper on the "the importance of Omega-3 fatty acids for heart health" notes that following review by FDA and the American Heart Association, "when it comes to omega-3s and heart health, the evidence is strongest for EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)," the Council for Responsible Nutrition states. The paper was released July 20 by CRN's Omega-3 Working Group. "It is important to educate various audiences on the benefits obtained from the different types of omega-3 fatty acids," according to Ian Newton, executive director of the working group. The paper "helps clarify some of the differences." FDA approved a qualified health claim for EPA and DHA in September (1"The Tan Sheet" Sept. 13, 2004, p. 12)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098451

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel